The Association for the Advancement of Blood and Biotherapies (AABB) is transforming patient care. We are driving policies to ensure patient access, expanding coverage for transformative therapies, advancing novel biotherapies research, and increasing the availability and access to safe biological products. AABB is instrumental in making biotherapies safe, effective and available worldwide.
AABB works collaboratively to advance the field through strategic partnerships and advocacy, support for leading-edge research and high-quality educational resources. AABB’s standards and accreditation program is the leader in ensuring the highest level of quality and safety for the blood and biotherapies field.